Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content ++ absolute risk reduction ++ Difference in event rates for two groups, usually treatment and control groups ++ adherence ++ The patient's ability or willingness to take a drug regimen that the practitioner has clinically judged to be appropriately indicated, effective, and, based on all available evidence, can produce the desired outcomes without any harmful effectsThe patient is able and willing to take the medication as intended. ++ advocacy (patient) ++ The willingness to assume an active role in obtaining resources or resolving problems on behalf of a patientMay require an intervention on the part of a health care professional for the benefit of a patient ++ assessment ++ A systematic review and appraisal of the patient's drug-related needsCompleted for the purpose of assuring that all the patient's drug therapy is appropriately indicated, the most effective available, and the safest possible assuring that the patient is able and willing to comply with the pharmacotherapeutic regimen, and identifying drug therapy problemsIncludes the decision-making processes of the Pharmacotherapy WorkupOne of three steps in the patient care process in the practice of pharmaceutical care (the care plan and the follow-up evaluation complete the process) ++ beneficence ++ Doing what is best for the patientOne of the primary ethical principles that underlies the practice of pharmaceutical care ++ care plan ++ A detailed schedule outlining the practitioner's and the patient's activities and responsibilities; designed to achieve goals of therapy, and resolve and prevent drug therapy problemsOrganized according to medical condition or indication for drug therapyIncludes (1) a statement of the goals of therapy; (2) the interventions by the practitioner and the actions to be taken by the patient to resolve any drug therapy problems, meet the goals of therapy, and prevent drug therapy problems; and (3) a schedule for the follow-up evaluation ++ caring ++ A state of responsiveness to others that entails the willingness to become personally involvedThe commitment to alleviate another person's vulnerability and sufferingConsidered to be the cornerstone of the therapeutic relationship and a principal component of the philosophy of pharmaceutical care practiceConsists of three activities that the practitioner must accomplish: (1) assess the patient's needs, (2) obtain the resources required to meet these needs, and (3) determine if the help provided has produced positive or negative outcomes ++ clinical pharmacy ++ An emphasis in the profession of pharmacy from the mid-1960s to the present, which moved the focus from drug product to patient-oriented services including consultationsIncludes a number of different services such as individualized (pharmacokinetic) dosing services, and drug utilization review, which are primarily provided in the institutional settingThe majority of the services are provided to/for physicians or at the request of physicians or are directed toward institutional policies and proceduresACCP Definition: A health ... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.